DCGODocGo Inc.

Nasdaq docgo.com


$ 3.09 $ -0.31 (-9.12 %)    

Thursday, 09-May-2024 15:00:41 EDT
QQQ $ 441.34 $ 0.88 (0.2 %)
DIA $ 393.80 $ 3.69 (0.95 %)
SPY $ 519.83 $ 2.39 (0.46 %)
TLT $ 90.72 $ 0.68 (0.76 %)
GLD $ 216.32 $ 1.62 (0.75 %)
$ 3.5
$ 3.40
$ 3.08 x 100
$ 3.10 x 100
$ 3.04 - $ 3.40
$ 2.78 - $ 10.82
1,332,949
na
379.77M
$ 1.16
$ 17.62
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
3 11-06-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-14-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-09-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 03-15-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 08-11-2021 06-30-2021 10-Q
13 06-03-2021 03-31-2021 10-Q
14 03-30-2021 12-31-2020 10-K
15 11-25-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 canaccord-genuity-maintains-buy-on-docgo-lowers-price-target-to-5

Canaccord Genuity analyst Richard Close maintains DocGo (NASDAQ:DCGO) with a Buy and lowers the price target from $9 to $5.

 needham-maintains-buy-on-docgo-lowers-price-target-to-7

Needham analyst Ryan MacDonald maintains DocGo (NASDAQ:DCGO) with a Buy and lowers the price target from $10 to $7.

 cantor-fitzgerald-maintains-overweight-on-docgo-lowers-price-target-to-5

Cantor Fitzgerald analyst Sarah James maintains DocGo (NASDAQ:DCGO) with a Overweight and lowers the price target from $11 t...

 docgo-sees-fy24-revenue-720m-750m-vs-747m-estimate

2024 GuidanceGiven that the previously forecasted wind-down of migrant related services has been accelerated, the Company is re...

 docgo-q1-2024-gaap-eps-010-beats-008-estimate-sales-19210m-beat-18793m-estimate

DocGo (NASDAQ:DCGO) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.08 by 25 per...

 stifel-maintains-buy-on-docgo-lowers-price-target-to-65

Stifel analyst David Grossman maintains DocGo (NASDAQ:DCGO) with a Buy and lowers the price target from $8 to $6.5.

 canaccord-genuity-maintains-buy-on-docgo-lowers-price-target-to-9

Canaccord Genuity analyst Richard Close maintains DocGo (NASDAQ:DCGO) with a Buy and lowers the price target from $10 to $9.

 why-ascent-solar-technologies-shares-are-trading-lower-by-around-50-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Ascent Solar Technologies, Inc. (NASDAQ: ASTI) fell sharply during Wednesday’s session after the company announced p...

 stifel-maintains-buy-on-docgo-lowers-price-target-to-8

Stifel analyst David Grossman maintains DocGo (NASDAQ:DCGO) with a Buy and lowers the price target from $11 to $8.

 btig-maintains-buy-on-docgo-lowers-price-target-to-11

BTIG analyst David Larsen maintains DocGo (NASDAQ:DCGO) with a Buy and lowers the price target from $13 to $11.

 smart-global-reports-q2-results-joins-health-catalyst-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session

U.S. stock futures were slightly higher this morning, with the Nasdaq futures gaining by around 0.1% on Wednesday.

 why-peraso-shares-are-trading-lower-by-over-23-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected four...

 national-cinemedia-reports-upbeat-results-joins-nordstrom-core--main-and-other-big-stocks-moving-higher-on-tuesday

U.S. stocks were mixed, with the Dow Jones index gaining around 75 points on Tuesday.

 docgo-tapped-board-member-steven-katz-as-the-chair-effective-april-1-2024-after-stan-vashovsky-retired-as-the-chair-and-director

On March 7, 2024, the Board of Directors (the “Board”) of DocGo Inc. (the “Company”) appointed Lee Bienstock, Chief Executive O...

 cantor-fitzgerald-maintains-overweight-on-docgo-lowers-price-target-to-11

Cantor Fitzgerald analyst Sarah James maintains DocGo (NASDAQ:DCGO) with a Overweight and lowers the price target from $13 t...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION